Coexistence of Hereditary Spastic Paraplegia Type 4 and Narcolepsy: A Case Report

被引:1
作者
Nagai, Takahiro [1 ,2 ]
Sunami, Yoko [3 ]
Kato, Risa
Sugai, Megumi [4 ]
Takahara, Makoto [5 ]
Ohta, Kentaro [1 ]
Fujinaka, Hidehiko [6 ,7 ]
Goto, Kiyoe [8 ]
Okanura, Osamu [4 ]
Nakajima, Takashi [1 ]
Ozawa, Tetsuo [5 ]
机构
[1] Natl Hosp Org Niigata Natl Hosp, Dept Neurol, Kashiwazaki, Japan
[2] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata, Japan
[3] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo, Japan
[4] Natl Hosp Org Niigata Natl Hosp, Dept Clin Lab, Kashiwazaki, Japan
[5] Natl Hosp Org Niigata Natl Hosp, Dept Internal Med, 3-52 Akasaka Cho, Kashiwazaki 9458585, Japan
[6] Natl Hosp Org Niigata Natl Hosp, Dept Pediat, Kashiwazaki, Japan
[7] Natl Hosp Org Niigata Natl Hosp, Dept Clin Res, Kashiwazaki, Japan
[8] Natl Hosp Org Niigata Natl Hosp, Dept Genet Counseling, Kashiwazaki, Japan
关键词
Spastic paraplegia; Spastic paraplegia type 4; Spastin; Narcolepsy; Hypocretin; EPIDEMIOLOGY; PEPTIDES; PROTEIN;
D O I
10.1159/000512404
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spastic paraplegia type 4 (SPG4) is the most common type of hereditary spastic paraplegia (HSP) caused by the mutations in the SPAST gene, which encodes a microtubule-severing protein named spastin. Spastin regulates the number and mobility of microtubules and is essential for axonal outgrowth and neuronal morphogenesis. Herein, we report a patient with SPG4 harboring a novel donor splice site mutation in the SPAST gene (c.1616+1dupG). Although SPG4 usually manifests itself as a pure form of HSP, this patient exhibited a slow progressive cognitive decline and also developed narcolepsy type 2 (narcolepsy without cataplexy) prior to the onset of SPG4. Recently, cognitive decline has attracted attention as a main non-motor symptom of SPG4. However, this is the first reported case of a patient developing both SPG4 and narcolepsy, although it remains unclear whether the manifestation of the two diseases is a coincidence or an association. In this report, we describe the clinical symptoms and genetic background of the patient.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 15 条
  • [1] [Anonymous], 2014, INT CLASSIFICATION S
  • [2] The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
    De Lecea, L
    Kilduff, TS
    Peyron, C
    Gao, XB
    Foye, PE
    Danielson, PE
    Fukuhara, C
    Battenberg, ELF
    Gautvik, VT
    Bartlett, FS
    Frankel, WN
    van den Pol, AN
    Bloom, FE
    Gautvik, KM
    Sutcliffe, JG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) : 322 - 327
  • [3] HARDING AE, 1983, LANCET, V1, P1151
  • [4] Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia
    Hazan, J
    Fonknechten, N
    Mavel, D
    Paternotte, C
    Samson, D
    Artiguenave, F
    Davoine, CS
    Cruaud, C
    Dürr, A
    Wincker, P
    Brottier, P
    Cattolico, L
    Barbe, V
    Burgunder, JM
    Prud'homme, JF
    Brice, A
    Fontaine, B
    Heilig, R
    Weissenbach, J
    [J]. NATURE GENETICS, 1999, 23 (03) : 296 - 303
  • [5] Identification and functional analysis of mutations in the Hypocretin (Orexin) genes of narcoleptic canines
    Hungs, M
    Fan, J
    Lin, L
    Lin, XY
    Maki, RA
    Mignot, E
    [J]. GENOME RESEARCH, 2001, 11 (04) : 531 - 539
  • [6] Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses
    Ishiura, Hiroyuki
    Takahashi, Yuji
    Hayashi, Toshihiro
    Saito, Kayoko
    Furuya, Hirokazu
    Watanabe, Mitsunori
    Murata, Miho
    Suzuki, Mikiya
    Sugiura, Akira
    Sawai, Setsu
    Shibuya, Kazumoto
    Ueda, Naohisa
    Ichikawa, Yaeko
    Kanazawa, Ichiro
    Goto, Jun
    Tsuji, Shoji
    [J]. JOURNAL OF HUMAN GENETICS, 2014, 59 (03) : 163 - 172
  • [7] JASPAC: Japan Spastic Paraplegia Research Consortium
    Koh, Kishin
    Ishiura, Hiroyuki
    Tsuji, Shoji
    Takiyama, Yoshihisa
    [J]. BRAIN SCIENCES, 2018, 8 (08):
  • [8] Dementia in SPG4 hereditary spastic paraplegia Clinical, genetic, and neuropathologic evidence
    Murphy, S.
    Gorman, G.
    Beetz, C.
    Byrne, P.
    Dytko, M.
    McMonagle, P.
    Kinsella, K.
    Farrell, M.
    Hutchinson, M.
    [J]. NEUROLOGY, 2009, 73 (05) : 378 - 384
  • [9] A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
    Peyron, C
    Faraco, J
    Rogers, W
    Ripley, B
    Overeem, S
    Charnay, Y
    Nevsimalova, S
    Aldrich, M
    Reynolds, D
    Albin, R
    Li, R
    Hungs, M
    Pedrazzoli, M
    Padigaru, M
    Kucherlapati, M
    Fan, J
    Maki, R
    Lammers, GJ
    Bouras, C
    Kucherlapati, R
    Nishino, S
    Mignot, E
    [J]. NATURE MEDICINE, 2000, 6 (09) : 991 - 997
  • [10] Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
    Richards, Sue
    Aziz, Nazneen
    Bale, Sherri
    Bick, David
    Das, Soma
    Gastier-Foster, Julie
    Grody, Wayne W.
    Hegde, Madhuri
    Lyon, Elaine
    Spector, Elaine
    Voelkerding, Karl
    Rehm, Heidi L.
    [J]. GENETICS IN MEDICINE, 2015, 17 (05) : 405 - 424